| pubmed-article:16504727 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16504727 | lifeskim:mentions | umls-concept:C0206153 | lld:lifeskim |
| pubmed-article:16504727 | lifeskim:mentions | umls-concept:C0665952 | lld:lifeskim |
| pubmed-article:16504727 | lifeskim:mentions | umls-concept:C0017431 | lld:lifeskim |
| pubmed-article:16504727 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:16504727 | lifeskim:mentions | umls-concept:C0445356 | lld:lifeskim |
| pubmed-article:16504727 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:16504727 | pubmed:dateCreated | 2006-2-28 | lld:pubmed |
| pubmed-article:16504727 | pubmed:abstractText | In a previous study we demonstrated that incompatibility regarding ligands for inhibitory killer immunoglobulin-like receptors (KIRs) is associated with a survival advantage following unrelated donor-hematopoietic cell transplantation (URD-HCT). The goal of the present analysis was to evaluate whether genotype of activating KIRs of the donor may have an impact on the outcome of URD-HCT. | lld:pubmed |
| pubmed-article:16504727 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16504727 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16504727 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16504727 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16504727 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16504727 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16504727 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16504727 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16504727 | pubmed:issn | 0041-1345 | lld:pubmed |
| pubmed-article:16504727 | pubmed:author | pubmed-author:BlochRR | lld:pubmed |
| pubmed-article:16504727 | pubmed:author | pubmed-author:HolowieckiJJ | lld:pubmed |
| pubmed-article:16504727 | pubmed:author | pubmed-author:WojnarJJ | lld:pubmed |
| pubmed-article:16504727 | pubmed:author | pubmed-author:MarkiewiczMM | lld:pubmed |
| pubmed-article:16504727 | pubmed:author | pubmed-author:NowakII | lld:pubmed |
| pubmed-article:16504727 | pubmed:author | pubmed-author:KusnierczykPP | lld:pubmed |
| pubmed-article:16504727 | pubmed:author | pubmed-author:Krawczyk-Kuli... | lld:pubmed |
| pubmed-article:16504727 | pubmed:author | pubmed-author:GiebelSS | lld:pubmed |
| pubmed-article:16504727 | pubmed:author | pubmed-author:DziaczkowskaJ... | lld:pubmed |
| pubmed-article:16504727 | pubmed:author | pubmed-author:WylezolII | lld:pubmed |
| pubmed-article:16504727 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16504727 | pubmed:volume | 38 | lld:pubmed |
| pubmed-article:16504727 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16504727 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16504727 | pubmed:pagination | 287-91 | lld:pubmed |
| pubmed-article:16504727 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:16504727 | pubmed:meshHeading | pubmed-meshheading:16504727... | lld:pubmed |
| pubmed-article:16504727 | pubmed:meshHeading | pubmed-meshheading:16504727... | lld:pubmed |
| pubmed-article:16504727 | pubmed:meshHeading | pubmed-meshheading:16504727... | lld:pubmed |
| pubmed-article:16504727 | pubmed:meshHeading | pubmed-meshheading:16504727... | lld:pubmed |
| pubmed-article:16504727 | pubmed:meshHeading | pubmed-meshheading:16504727... | lld:pubmed |
| pubmed-article:16504727 | pubmed:meshHeading | pubmed-meshheading:16504727... | lld:pubmed |
| pubmed-article:16504727 | pubmed:meshHeading | pubmed-meshheading:16504727... | lld:pubmed |
| pubmed-article:16504727 | pubmed:meshHeading | pubmed-meshheading:16504727... | lld:pubmed |
| pubmed-article:16504727 | pubmed:meshHeading | pubmed-meshheading:16504727... | lld:pubmed |
| pubmed-article:16504727 | pubmed:meshHeading | pubmed-meshheading:16504727... | lld:pubmed |
| pubmed-article:16504727 | pubmed:meshHeading | pubmed-meshheading:16504727... | lld:pubmed |
| pubmed-article:16504727 | pubmed:meshHeading | pubmed-meshheading:16504727... | lld:pubmed |
| pubmed-article:16504727 | pubmed:meshHeading | pubmed-meshheading:16504727... | lld:pubmed |
| pubmed-article:16504727 | pubmed:meshHeading | pubmed-meshheading:16504727... | lld:pubmed |
| pubmed-article:16504727 | pubmed:meshHeading | pubmed-meshheading:16504727... | lld:pubmed |
| pubmed-article:16504727 | pubmed:meshHeading | pubmed-meshheading:16504727... | lld:pubmed |
| pubmed-article:16504727 | pubmed:articleTitle | Impact of activating killer immunoglobulin-like receptor genotype on outcome of unrelated donor-hematopoietic cell transplantation. | lld:pubmed |
| pubmed-article:16504727 | pubmed:affiliation | Department of Hematology and BMT, Silesian Medical University, ul. Reymonta 8, 40-029 Katowice, Poland. sgiebel@poczta.onet.pl | lld:pubmed |
| pubmed-article:16504727 | pubmed:publicationType | Journal Article | lld:pubmed |
| entrez-gene:3806 | entrezgene:pubmed | pubmed-article:16504727 | lld:entrezgene |
| entrez-gene:100132285 | entrezgene:pubmed | pubmed-article:16504727 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16504727 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16504727 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16504727 | lld:pubmed |
